You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR APTIOM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for APTIOM

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02912364 ↗	Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults	Completed	Sunovion	Phase 4	2016-07-01	Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.
NCT02912364 ↗	Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults	Completed	Stanford University	Phase 4	2016-07-01	Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.
NCT03108729 ↗	A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug	Withdrawn	Sunovion	Phase 3	2017-07-06	A pediatric drug study to determine the long-term safety and tolerability in children and adolescents (4-17 years in age) taking the drug (elsicarbazepine acetate)
NCT03116828 ↗	A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures	Completed	Sunovion	Phase 4	2017-07-07	A study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset Seizures
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for APTIOM

Condition Name

Chart
Table

Condition Name for APTIOM
Intervention	Trials
Epilepsy	2
Epilepsy With Partial On-set Seizures	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for APTIOM
Intervention	Trials
Epilepsy	3
Seizures	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for APTIOM

Trials by Country

Map
Table

Trials by Country for APTIOM
Location	Trials
United States	31
Canada	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for APTIOM
Location	Trials
Florida	2
California	2
Texas	1
Tennessee	1
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for APTIOM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for APTIOM
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for APTIOM
Clinical Trial Phase	Trials
Completed	2
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for APTIOM

Sponsor Name

Chart
Table

Sponsor Name for APTIOM
Sponsor	Trials
Sunovion	3
Stanford University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for APTIOM
Sponsor	Trials
Industry	3
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.